EDEN PRAIRIE, Minn.–(BUSINESS WIRE)– SurModics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, will hold its Annual Meeting of Shareholders on Wednesday, February 21, at 4:00 p.m. CT (5:00 p.m. ET), as a virtual meeting. Gary Maharaj, chief executive officer, and Sue Knight, chair of the board, will provide […]
Financial
Global Heart Valve Devices Market 2017-2025 Size, Market Share, Application Analysis, Growth Trends, and Key Players – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Heart Valve Devices Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025” report has been added to ResearchAndMarkets.com’s offering. The global heart valve devices market was valued at US$ 4,945 Mn in 2016, and is expected to reach US$ 13,377.9 Mn […]
Bay Area Medical Device Firm Acquires Corpus Medical
FREMONT, Calif.–(BUSINESS WIRE)– Confluent Medical Technologies(“Confluent Medical”), a global leader in medical device contract manufacturing, today completed the acquisition of Corpus Medical, Inc.. Confluent Medical is a contract manufacturer with full scale capabilities to provide high-quality, low cost finished class III medical devices. Confluent’s core capabilities revolve around industry-leading expertise in balloon […]
InspireMD Announces 1-for-35 Reverse Stock Split
Tel Aviv, Israel, Feb. 07, 2018 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE American: NSPR, NSPR.WS, NSPR.WSB), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced a 1-for-35 reverse split of its common stock, effective as of February 7, 2018. Beginning on February 8, […]
Surmodics Reports First Quarter Fiscal 2018 Results, Updates Fiscal 2018 Guidance
Feb. 8, 2018 12:30 UTC EDEN PRAIRIE, Minn.–(BUSINESS WIRE)– SurModics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced results for its fiscal 2018 first quarter, ended December 31, 2017, and updated financial outlook for fiscal 2018. “We are making steady […]
Cardiovascular Systems Names a New CFO, Effective Immediately
Feb. 7, 2018 21:06 UTC Cardiovascular Systems, Inc. Appoints Jeff Points as Chief Financial Officer Larry Betterley to Retire in August 2018 ST. PAUL, Minn.–(BUSINESS WIRE)– Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII) announced today that Jeff Points was named Chief Financial Officer (CFO), effective immediately. As part of a planned succession, Points […]
JenaValve Raises $5 Million
JenaValve raises $5m FEBRUARY 6, 2018 BY FINK DENSFORD of MassDevice As first reported by Fink Densford of MassDevice: JenaValve Technology has raised $4.9 million in a new round of debt financing, according to an SEC filing posted this week. The Irvine, Calif.-based company is one of several smaller players looking to enter the […]
REVA Announces Appointment of Stephen Oesterle, MD to Board of Directors
SAN DIEGO, Feb. 05, 2018 (GLOBE NEWSWIRE) — REVA Medical (ASX:RVA) (“REVA” or the “Company”), a leader in bioresorbable polymer technologies for vascular applications, announces the appointment of Stephen Oesterle, MD to its Board of Directors, effective immediately. Dr. Oesterle brings significant clinical, medical device and board expertise to REVA. He is […]
The vascular grafts market is expected to reach USD 3.80 billion by 2022 from USD 2.67 billion in 2017, at a CAGR of 7.3%
LONDON, Jan. 31, 2018 /PRNewswire/ — The vascular grafts market is expected to reach USD 3.80 billion by 2022 from USD 2.67 billion in 2017, at a CAGR of 7.3%. The major factors driving the growth of this market are the high burden of abdominal aneurysms, increasing geriatric population, and increasing prevalence of smoking & other […]
Varian to Discuss Agreement to Acquire Sirtex
PALO ALTO, Calif., Jan. 30, 2018 /PRNewswire/ — Varian (NYSE: VAR) today announced that it will webcast a conference call to discuss the details of the agreement, also announced today, to acquire all the outstanding shares of Sirtex Medical. Sirtex is an Australia-based global life sciences company focused on interventional oncology therapies, that is […]



